NPI: 1255308722 · FORT MYERS, FL 33916 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/03/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/03/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,914 | $4.05M |
| 2019 | 31,242 | $5.79M |
| 2020 | 35,000 | $4.95M |
| 2021 | 33,522 | $2.74M |
| 2022 | 19,465 | $2.42M |
| 2023 | 7,856 | $642K |
| 2024 | 713 | $27K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 47,289 | 3,027 | $6.71M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 45,448 | 2,239 | $5.53M |
| J1270 | Injection, doxercalciferol, 1 mcg | 25,176 | 1,698 | $3.56M |
| J1756 | Injection, iron sucrose, 1 mg | 11,373 | 2,162 | $1.51M |
| A4657 | Syringe, with or without needle, each | 4,966 | 2,423 | $1.30M |
| 85041 | 2,749 | 1,901 | $389K | |
| 85048 | 2,746 | 1,900 | $377K | |
| 83970 | 2,400 | 1,643 | $358K | |
| 82728 | 1,482 | 1,063 | $240K | |
| 83540 | 1,487 | 1,062 | $224K | |
| 83550 | 1,454 | 1,035 | $223K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 656 | 362 | $65K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 882 | 84 | $65K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 385 | 254 | $45K |
| G0008 | Administration of influenza virus vaccine | 124 | 95 | $15K |
| 90674 | 95 | 69 | $12K |